Word

Status

Pending

Status Code

630

Status Date

Friday, January 5, 2024

Serial Number

98343462

Mark Type

2

Filing Date

Friday, January 5, 2024

Trademark Owner History

MagForce NT GmbH

Classifications

5 Diagnostic agents for medical purposes, diagnostic preparations for medical purposes, and pharmaceutical, veterinary and medical preparations for the treatment of malignant or benign tumor diseases, cardiovascular diseases, arthritis, arthrosis, arteriosclerosis, stenosis, restenosis and/or skin diseases containing magnetic particles, namely, magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles comprising iron oxide; pharmaceutical preparations containing metallic or magnetic particles in the nature of nanoparticles for use as anticarcinogenic agents and/or antineoplastic agents, and for treating malignant or benign tumor diseases, cardiovascular diseases, arthritis, arthrosis, arteriosclerosis, stenosis, restenosis and/or skin diseases; contrasting agents for diagnostic imaging for medical purposes; none of the foregoing to be used with radiotherapy for cancer treatment

1 Chemical products, namely, magnetic nanoparticles composed of iron oxide for use in industry and research; chemical metallic or magnetic particles and nanometer particles for use in industry and research; biopolymers containing metallic nanoparticles for use in industry and research; synthetic and natural oxides in the form of granules and granulates containing iron oxide, in particular magnetite and maghemite; chemical products in the form of magnetic nanoparticles, namely, superparamagnetic nanoparticles and superparamagnetic iron oxide nanoparticles for use in industry and research; chemical preparations in the form of biocompatible polymer nanoparticles, liposomes, coated nanoparticles, and drug-containing nanoparticles, all of the foregoing for use in industry and research, namely, for use in therapy methods, thermotherapy methods, thermoablation methods and/or hyperthermia methods, but not including radiotherapy methods

44 Medical services, namely, cancer and cardiovascular therapy, cancer and cardiovascular treatment, and medical diagnosis of cancer and cardiovascular diseases in the nature of dispensing of medical diagnostics and pharmaceutical and medical preparations containing magnetic particles; conducting medical device-based therapeutic or diagnostic methods, namely, providing physical therapy using magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles containing iron oxide; medical services, namely, treatment of malignant or benign tumor diseases, cardiovascular diseases, arthritis, arthrosis, arteriosclerosis, stenosis, restenosis and/or skin diseases; medical services, namely, thermotherapeutic services, thermoablation methods and/or hyperthermia methods for cancer and cardiovascular treatment using magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles; providing medical testing for diagnostic or treatment purposes in the field of cancer and cardiovascular treatment; none of the foregoing services comprising radiotherapy in cancer treatment

10 Medical devices containing magnetic particles, namely, magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles containing iron oxide, magnetic powders, granules, and granulates containing iron oxide for use in thermotherapy methods, thermoablation methods and/or hyperthermia methods, and none of the foregoing devices comprising compression equipment systems or apparatus or equipment for radiotherapy

42 Medical and scientific research in the field of cancer and/or cardiovascular treatment and diagnosis; development and design of medical devices containing magnetic particles, namely, magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles containing iron oxide, all for treatment and/or diagnosis of cancer and/or cardiovascular diseases; providing medical testing and information in the field of cancer and cardiovascular research; none of the foregoing services comprising radiotherapy in cancer treatment

The mark consists of a dot with two curvy lines on either side and straight lines in between the curvy lines and in the middle of the arcs formed by the curvy lines.
Color is not claimed as a feature of the mark.

Trademark Events

Jan 5, 2024

New Application Entered

Apr 22, 2024

Notice Of Design Search Code E-Mailed

Apr 22, 2024

New Application Office Supplied Data Entered